Skip to content
10-Q

Quarterly Report

CALYPTE BIOMEDICAL CORP

0001437749-12-013311

← back to feed
Filed
Dec 31, 2012 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2012 · Dec 31, 2012 700.17M sh
Shares Diluted Q3 2012 · Sep 30, 2012 700.17M sh
Shares Diluted Q3 2012 · Sep 30, 2012 655.69M sh
Shares Diluted Q3 2012 · Sep 30, 2011 547.83M sh
Shares Diluted Q3 2012 · Sep 30, 2011 545.19M sh
Operating Cash Flow Q3 2012 · Sep 30, 2012 −$544K
Operating Cash Flow Q3 2012 · Sep 30, 2011 −$243K
Cash And Equivalents Q3 2012 · Sep 30, 2012 $5K
Cash And Equivalents Q3 2012 · Dec 31, 2011 $10K
Cash And Equivalents Q3 2012 · Sep 30, 2011 $73K
Cash And Equivalents Q3 2012 · Dec 31, 2010 $79K
Stockholders Equity Q3 2012 · Sep 30, 2012 −$4.98M
Stockholders Equity Q3 2012 · Dec 31, 2011 −$5.11M
Current Liabilities Q3 2012 · Sep 30, 2012 $3.05M
Current Liabilities Q3 2012 · Dec 31, 2011 $3.41M
Total Liabilities Q3 2012 · Sep 30, 2012 $6.8M
Total Liabilities Q3 2012 · Dec 31, 2011 $7.07M
Current Assets Q3 2012 · Sep 30, 2012 $211K
Current Assets Q3 2012 · Dec 31, 2011 $227K
Total Assets Q3 2012 · Sep 30, 2012 $1.82M
Total Assets Q3 2012 · Dec 31, 2011 $1.96M
Sga Expense Q3 2012 · Sep 30, 2012 $169K
Sga Expense Q3 2012 · Sep 30, 2012 $535K
Sga Expense Q3 2012 · Sep 30, 2011 $213K
Sga Expense Q3 2012 · Sep 30, 2011 $667K
Rd Expense Q3 2012 · Sep 30, 2012 $62K
Rd Expense Q3 2012 · Sep 30, 2012 $204K
Rd Expense Q3 2012 · Sep 30, 2011 $85K
Rd Expense Q3 2012 · Sep 30, 2011 $226K
Net Income Q3 2012 · Sep 30, 2012 −$261K
Net Income Q3 2012 · Sep 30, 2012 −$788K
Net Income Q3 2012 · Sep 30, 2011 −$242K
Net Income Q3 2012 · Sep 30, 2011 −$437K
Operating Income Q3 2012 · Sep 30, 2012 −$233K
Operating Income Q3 2012 · Sep 30, 2012 −$696K
Operating Income Q3 2012 · Sep 30, 2011 −$218K
Operating Income Q3 2012 · Sep 30, 2011 −$743K
Cost Of Revenue Q3 2012 · Sep 30, 2012 $35K
Cost Of Revenue Q3 2012 · Sep 30, 2012 $124K
Cost Of Revenue Q3 2012 · Sep 30, 2011 $27K
Cost Of Revenue Q3 2012 · Sep 30, 2011 $355K
Stock Issued Q3 2012 · Feb 28, 2011 6M sh
Stock Issued Q3 2012 · Jan 31, 2011 16.67M sh